Showing results (91-100 of 1,399) with videos related to
Sort By:
Pageof 140
Pharmacology Research & Perspectives|July 15, 2015
Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical modelsMukul R Jain, Suresh R Giri, Chitrang Trivedi, et al.Pharmacology Research & Perspectives|July 15, 2015
Reduced activity of SKC a and Na-K ATPase underlies the accelerated impairment of EDH-type relaxations in mesenteric arteries of aging spontaneously hypertensive ratsBilly W C Kong, Ricky Y K Man, Yuansheng Gao, et al.Pharmacology Research & Perspectives|July 15, 2015
Propofol restores TRPV1 sensitivity via a TRPA1-, nitric oxide synthase-dependent activation of PKCεPritam Sinharoy, Hongyu Zhang, Sayantani Sinha, et al.Pharmacology Research & Perspectives|July 15, 2015
Effect of CYP3A perpetrators on ibrutinib exposure in healthy participantsJan de Jong, Donna Skee, Joe Murphy, et al.Pharmacology Research & Perspectives|April 9, 2020
The influence of ABCG2 polymorphism on erlotinib efflux in the K562 cell lineAnna Svedberg, Lianne Jacobs, Svante Vikingsson, et al.Pharmacology Research & Perspectives|July 20, 2016
Niacin promotes revascularization and recovery of limb function in diet-induced obese mice with peripheral ischemiaDominic K T Pang, Zengxuan Nong, Brian G Sutherland, et al.Pharmacology Research & Perspectives|July 20, 2016
Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelinesNathalie Vernaz, Victoria Rollason, Liene Adlere, et al.Pharmacology Research & Perspectives|July 20, 2016
A randomized, crossover pharmacodynamic study of immediate-release omeprazole/sodium bicarbonate and delayed-release lansoprazole in healthy adult volunteersVijayalakshmi S Pratha, Thomas McGraw, William TobinPharmacology Research & Perspectives|July 22, 2015
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonistChaela Presley, Ammaar Abidi, Satyendra Suryawanshi, et al.Pharmacology Research & Perspectives|June 13, 2017
A three-parameter two-state model of receptor function that incorporates affinity, efficacy, and signal amplificationPeter BuchwaldPageof 140